---
title: "Stifel Nicolaus Remains a Buy on ATS Corporation (ATS)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285337256.md"
description: "Stifel Nicolaus analyst Justin Keywood has reaffirmed a Buy rating on ATS Corporation (ATS) with a price target of C$52.00. This follows a similar Buy rating from Scotiabank, which set a price target of C$51.00. Keywood specializes in the Healthcare sector and has an average return of -1.5% with a 50.94% success rate on his stock recommendations."
datetime: "2026-05-06T08:06:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285337256.md)
  - [en](https://longbridge.com/en/news/285337256.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285337256.md)
---

# Stifel Nicolaus Remains a Buy on ATS Corporation (ATS)

In a report released yesterday, Justin Keywood from Stifel Nicolaus maintained a Buy rating on ATS Corporation, with a price target of C$52.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Keywood covers the Healthcare sector, focusing on stocks such as WELL Health Technologies Corp, NervGen Pharma, and HEALWELL AI. According to TipRanks, Keywood has an average return of \-1.5% and a 50.94% success rate on recommended stocks.

In a report released on April 28, Scotiabank also maintained a Buy rating on the stock with a C$51.00 price target.

### Related Stocks

- [ATS.US](https://longbridge.com/en/quote/ATS.US.md)

## Related News & Research

- [Pizza Pizza Royalty slashes monthly dividend by 12.9% to CAD 0.0675 a share](https://longbridge.com/en/news/286714154.md)
- [Virtuix Expands Into AI-Assisted Neurodivergent Therapy Through Rutgers University Collaboration | VTIX Stock News](https://longbridge.com/en/news/287075316.md)
- [LifeSci Capital Sticks to Their Buy Rating for MoonLake Immunotherapeutics (MLTX)](https://longbridge.com/en/news/286649191.md)
- [UnitedHealth Group Incorporated $UNH Holdings Boosted by GSA Capital Partners LLP](https://longbridge.com/en/news/286878927.md)
- [Stifel Nicolaus Sticks to Its Buy Rating for CAE (CAE)](https://longbridge.com/en/news/286124486.md)